Form 4: LifeStance Health Group Executive Kevin Mullins Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Kevin Michael Mullins, Chief Development Officer of LifeStance Health Group, sold 115,136 shares of common stock at an average price of $8.02 on March 1, 2024, under a pre-arranged trading plan.
Summary
- On March 1, 2024, Kevin Michael Mullins, the Chief Development Officer of LifeStance Health Group, sold 115,136 shares of common stock.
- The sale was executed at a weighted average price of $8.02 per share, with individual transactions ranging from $8.00 to $8.25.
- The transactions were conducted under a Rule 10b5-1 trading plan adopted on December 9, 2022.
- Following the reported transaction, Mullins beneficially owns 4,575,480 shares of LifeStance Health Group.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating an insider share sale. The sentiment is neutral as it simply reports a transaction executed under a pre-existing trading plan.
Industry Context
Sales by company insiders are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to sell shares over a period of time without being accused of trading on non-public information. The market typically views these sales in the context of the overall insider ownership and the reasons behind the trading plan.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, potentially leading to a slight decrease in investor confidence.
- However, the existence of a 10b5-1 trading plan mitigates this concern, as it indicates the sale was pre-planned and not based on current insider information.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-03-01 | Date of transaction (sale of shares) |
| 2024-03-04 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.